logo-loader
viewTHC Global Group Ltd

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.
 
"It's a significnat milestone ... we now are a farm-to-pharma process which means that we grow, and we actually then process to a complete medicine," says Charteris. 
 
He continues, "This is a great position for us to be in and we're the only company presently that holds the whole suite and also have their own breeds and processing. 
 
"The bigger news for us is that we're a global company - this now allows us to produce and formulate our own brands with our own products."

Quick facts: THC Global Group Ltd

Price: 0.415 AUD

ASX:THC
Market: ASX
Market Cap: $56.72 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global starts manufacturing at Southport facility after green light from...

THC Global Group Ltd’s (ASX:THC) group chief executive officer Ken Charteris updates Proactive after the company received a key medicinal cannabis manufacture permit for its Southport facility from the Australia regulator, allowing production to start immediately. Charteris says this is...

1 week, 2 days ago

2 min read